Dosage Forms

Dec 07, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
Principles of dissolution testing, including method development and testing apparatus, are reviewed.
Nov 02, 2016
Pharmaceutical Technology
A dissolution method should have adequate discriminatory power to detect formulation changes that affect the dissolution rate of a drug product.
Nov 02, 2016
Pharmaceutical Technology
This article will clarify reasonable expectations for the responsibilities of topical product formulation developers and for excipient suppliers regarding the information and samples for experiments needed for QbD.
Oct 02, 2016
Pharmaceutical Technology
Understanding the components of a reference marketed pMDI is needed to develop a generic pMDI.
Oct 02, 2016
Pharmaceutical Technology
This article will equip the excipient vendor with an understanding of QbD from the perspective of the topical pharmaceutical product manufacturer.
Sep 01, 2016
Pharmaceutical Technology
The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.
Sep 01, 2016
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.
Sep 01, 2016
Pharmaceutical Technology
A study demonstrates the feasibility of a novel solid-dose formulation injection technology to effectively deliver a therapeutic treatment without the aid of a needle.
Jun 08, 2016
Pharmaceutical Technology sat down with Charles N. Kettler, PhD, director of Natoli Scientific, to discuss the Natoli Institute for Industrial Pharmacy at Long Island University.
May 31, 2016
By Pharmaceutical Technology Editors
The agency publishes draft guidance on assessing the adhesion of transdermal delivery systems and topical patches.
native1_300x100
lorem ipsum